Aptose Biosciences Shareholders Approve Key Proposals

Aptose Biosciences (TSE:APS) has released an update.

Aptose Biosciences Inc. reports successful shareholder meeting results, with all director nominees re-elected and key proposals approved. Shareholders voted for the re-appointment of KPMG LLP as the independent auditor and passed an advisory resolution on executive compensation. Additionally, the issuance of common shares to certain warrant holders was approved, in compliance with Nasdaq Listing Rules.

For further insights into TSE:APS stock, check out TipRanks’ Stock Analysis page.